Endogenous phospholipase A2 inhibitors in snakes: a brief overview

AUTOR(ES)

Campos, Patrícia Cota, Melo, Lutiana Amaral de, Dias, Gabriel Latorre Fortes, Fortes-Dias, Consuelo Latorre

FONTE

J. Venom. Anim. Toxins incl. Trop. Dis

DATA DE PUBLICAÇÃO

19/01/2017

RESUMO

Abstract The blood plasma of numerous snake species naturally comprises endogenous phospholipase A2 inhibitors, which primarily neutralize toxic phospholipases A2 that may eventually reach their circulation. This inhibitor type is generally known as snake blood phospholipase A2 inhibitors (sbPLIs). Most, if not all sbPLIs are oligomeric glycosylated proteins, although the carbohydrate moiety may not be essential for PLA2 inhibition in every case. The presently known sbPLIs belong to one of three structural classes – namely sbαPLI, sbβPLI or sbγPLI – depending on the presence of characteristic C-type lectin-like domains, leucine-rich repeats or three-finger motifs, respectively. Currently, the most numerous inhibitors described in the literature are sbαPLIs and sbγPLIs, whereas sbβPLIs are rare. When the target PLA2 is a Lys49 homolog or an Asp49 myotoxin, the sbPLI is denominated a myotoxin inhibitor protein (MIP). In this brief overview, the most relevant data on sbPLIs will be presented. Representative examples of sbαPLIs and sbγPLIs from two Old World – Gloydius brevicaudus and Malayopython reticulatus – and two New World – Bothrops alternatus and Crotalus durissus terrificus – snake species will be emphasized.

Documentos Relacionados

• Myotoxic Phospholipases A2 from Venoms of Crotalid Snakes: Properties, Actions, and Neutralization
• Alpha-type phospholipase A2 inhibitors from snake blood
• Activation of high levels of endogenous phospholipase A2 in cultured cells.
• Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.
• New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase